• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成及评价一种对前列腺特异膜抗原(PSMA)和骨具有高亲和力的多功能探针。

Synthesis and evaluation of a multifunctional probe with a high affinity for prostate-specific membrane antigen (PSMA) and bone.

机构信息

Graduate School of Medical Sciences, Kanazawa University, Kanazawa 920-1192, Japan.

Institute for Frontier Science Initiative, Kanazawa University, Kanazawa 920-1192, Japan.

出版信息

Nucl Med Biol. 2022 Nov-Dec;114-115:34-41. doi: 10.1016/j.nucmedbio.2022.08.004. Epub 2022 Aug 24.

DOI:10.1016/j.nucmedbio.2022.08.004
PMID:36088875
Abstract

Prostate cancer frequently metastasizes to the bone. Because patients with bone metastases suffer from skeletal-related events, the diagnosis and treatment of bone metastases in the early stage are important. In this study, to improve the sensitivity of detecting bone metastases in patients with prostate cancer, we designed, synthesized, and evaluated a multifunctional radiotracer, [Ga]Ga-D-PSMA-617 ([Ga]3), with an undeca-aspartic acid as a bone-seeking moiety between [Ga]Ga-DOTA and a prostate-specific membrane antigen (PSMA) ligand based on the lysine-urea-glutamate motif. [Ga]3 showed a high affinity for hydroxyapatite and high uptake in PSMA-positive LNCaP cells. Moreover, in biodistribution experiments using tumor-bearing mice, [Ga]3 exhibited high accumulation in the bone and PSMA-positive tumor although the accumulation of [Ga]3 in the PSMA-positive tumor was lower than that of [Ga]Ga-PSMA-617. This study provides valuable information for developing radiotheranostic probes combining multiple carriers with different mechanisms.

摘要

前列腺癌常转移至骨骼。由于骨转移患者会发生与骨骼相关的事件,因此早期诊断和治疗骨转移非常重要。在这项研究中,为了提高前列腺癌患者骨转移检测的灵敏度,我们设计、合成并评估了一种多功能放射性示踪剂[Ga]Ga-D-PSMA-617([Ga]3),该示踪剂以天冬氨酸作为连接物,将[Ga]Ga-DOTA 和基于赖氨酸-脲-谷氨酸基序的前列腺特异性膜抗原(PSMA)配体连接起来。[Ga]3 对羟磷灰石具有高亲和力,并且在 PSMA 阳性的 LNCaP 细胞中有高摄取率。此外,在荷瘤小鼠的生物分布实验中,[Ga]3 在骨和 PSMA 阳性肿瘤中有高蓄积,尽管[Ga]3 在 PSMA 阳性肿瘤中的蓄积低于[Ga]Ga-PSMA-617。本研究为开发结合不同机制的多种载体的放射性治疗探针提供了有价值的信息。

相似文献

1
Synthesis and evaluation of a multifunctional probe with a high affinity for prostate-specific membrane antigen (PSMA) and bone.合成及评价一种对前列腺特异膜抗原(PSMA)和骨具有高亲和力的多功能探针。
Nucl Med Biol. 2022 Nov-Dec;114-115:34-41. doi: 10.1016/j.nucmedbio.2022.08.004. Epub 2022 Aug 24.
2
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
3
Effects of Linker Modification on Tumor-to-Kidney Contrast of Ga-Labeled PSMA-Targeted Imaging Probes.连接子修饰对 Ga 标记的 PSMA 靶向成像探针肿瘤与肾脏对比的影响。
Mol Pharm. 2018 Aug 6;15(8):3502-3511. doi: 10.1021/acs.molpharmaceut.8b00499. Epub 2018 Jul 3.
4
Halogen Replacement on the Lysine Side Chain of Lys-Urea-Glu-Based PSMA Inhibitors Leads to Significant Changes in Targeting Properties.基于赖氨酸-尿素-谷氨酸的前列腺特异性膜抗原(PSMA)抑制剂赖氨酸侧链上的卤素取代导致靶向特性发生显著变化。
Mol Imaging Biol. 2023 Aug;25(4):765-775. doi: 10.1007/s11307-023-01804-x. Epub 2023 Jan 25.
5
Synthesis and evaluation of a novel urea-based Ga-complex for imaging PSMA binding in tumor.新型基于尿素的 Ga 配合物的合成与评价及其在 PSMA 结合肿瘤成像中的应用。
Nucl Med Biol. 2018 Apr;59:36-47. doi: 10.1016/j.nucmedbio.2017.12.007. Epub 2017 Dec 27.
6
Development of a Ga-68 labeled PET tracer with short linker for prostate-specific membrane antigen (PSMA) targeting.开发一种带有短接头的 Ga-68 标记的 PET 示踪剂,用于前列腺特异性膜抗原(PSMA)靶向。
Bioorg Med Chem. 2018 May 15;26(9):2501-2507. doi: 10.1016/j.bmc.2018.04.014. Epub 2018 Apr 5.
7
In vitro and in vivo comparative study of a novel Ga-labeled PSMA-targeted inhibitor and Ga-PSMA-11.新型 Ga 标记 PSMA 靶向抑制剂与 Ga-PSMA-11 的体外与体内比较研究。
Sci Rep. 2021 Sep 27;11(1):19122. doi: 10.1038/s41598-021-98555-y.
8
Ga-labeled ODAP-Urea-based PSMA agents in prostate cancer: first-in-human imaging of an optimized agent.Ga 标记的基于 ODAP-尿素的 PSMA 探针在前列腺癌中的应用:优化探针的首例人体成像研究。
Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):1030-1040. doi: 10.1007/s00259-021-05486-x. Epub 2021 Aug 28.
9
Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis.Ga 标记前列腺特异性膜抗原配体正电子发射断层扫描/计算机断层扫描在前列腺癌中的应用:系统评价和荟萃分析。
Eur Urol Focus. 2018 Sep;4(5):686-693. doi: 10.1016/j.euf.2016.11.002. Epub 2016 Nov 15.
10
Synthesis and Evaluation of Ga- and Lu-Labeled ()- vs ()-DOTAGA Prostate-Specific Membrane Antigen-Targeting Derivatives.镓和镥标记的 ()-与 ()-DOTAGA 前列腺特异性膜抗原靶向衍生物的合成与评价。
Mol Pharm. 2020 Dec 7;17(12):4589-4602. doi: 10.1021/acs.molpharmaceut.0c00777. Epub 2020 Oct 27.

引用本文的文献

1
Development of a Theranostic Agent for Bone Metastases: Integration of Nuclear Medicine Imaging and Boron Neutron Capture Therapy (BNCT).用于骨转移的诊疗剂的开发:核医学成像与硼中子俘获疗法(BNCT)的整合
Mol Pharm. 2025 Sep 1;22(9):5546-5554. doi: 10.1021/acs.molpharmaceut.5c00572. Epub 2025 Aug 20.
2
Engineering a Radiohybrid PSMA Ligand with an Albumin-Binding Moiety and Pharmacokinetic Modulation via an Albumin-Binding Competitor for Radiotheranostics.通过白蛋白结合竞争剂设计一种具有白蛋白结合部分并进行药代动力学调控的放射性杂交PSMA配体用于放射治疗诊断。
Molecules. 2025 Jun 29;30(13):2804. doi: 10.3390/molecules30132804.
3
Future Prospect of Low-Molecular-Weight Prostate-Specific Membrane Antigen Radioisotopes Labeled as Theranostic Agents for Metastatic Castration-Resistant Prostate Cancer.
低分子量前列腺特异性膜抗原放射性同位素标记作为转移性去势抵抗性前列腺癌治疗诊断剂的未来前景
Molecules. 2024 Dec 23;29(24):6062. doi: 10.3390/molecules29246062.
4
Differences in the Renal Accumulation of Radiogallium-Labeled (Glu) Peptides Containing Different Optical Isomers of Glutamic Acid.不同光学异构体谷氨酸标记(Glu)肽的肾蓄积差异。
Molecules. 2024 Aug 23;29(17):3993. doi: 10.3390/molecules29173993.